Skip to content

Clinical trials

Urinary Bladder Neoplasms trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Country / region: Sweden Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20081
20121
20131
20141
20152
20161
20173
20181
20193
20202
20221
20233
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting6
Active, not recruiting3
Terminated3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC4
Bristol-Myers Squibb3
Dr Anders Ullén2
Rainier Therapeutics2
Vastra Gotaland Region2
Fore Biotherapeutics1
Genentech, Inc.1
Hoffmann-La Roche1
Jens Nielsen1
Karolinska Institutet1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms28
Carcinoma, Transitional Cell8
Kidney Neoplasms3
Ovarian Neoplasms3
Prostatic Neoplasms3
Ureteral Neoplasms3
Breast Neoplasms2
Colorectal Neoplasms2
Neoplasms2
Urethral Neoplasms2

Trials

Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.